The Alliance is proud to share that Cynthia Bens, our Vice President of Public Policy, will present on a panel at the DIA 28th Annual EuroMeeting in Hamburg, Germany:
Frailty as a Baseline Stratification Parameter and Potential Therapeutic Target April 7, 2016 11:00 AM – 12:30 PM (Central European Standard Time) Track: Special Populations Session Number: S1102
Progress made in drug development for and with older people? This session will announce and discuss the brand new EMA Geriatric Working Party frailty definition selected for study baseline characteristics for clinical studies and propose how this will change the research landscape in geriatric studies in Europe and beyond.
Chair: Florian von Raison, Dr Med Senior Global Program Head and Chairman Geriatric Medicine Working Party/ EFGCP Novartis Pharma AG, Switzerland
Presentation(s) & Speaker(s):
The EMA Geriatric Medicines Strategy, Good Pharmacovigilance Practice (GVP) and What Leads Us to Single out Frailty Susan Morgan Medical Assessor Medicines & Healthcare Products Regulatory Agency (MHRA) United Kingdom
SPRINTT- IMI Susanna Del Signore, MD Director and Founder Bluecompanion United Kingdom
The Frailty Guideline under Consultation: What Does It Mean in Terms of CT Population and Registries Antonio Cherubini Head of Geriatrics IRCCS-INRCA Italy
Addressing Areas of Need / Insufficient Research Cynthia Bens VP, Public Policy Alliance for Aging Research United States
Roundtable Discussion Francesca Cerreta, PharmD, MPharm, MS Senior Scientific Officer European Medicines Agency European Union, United Kingdom
Living Longer and Loving It
Sign up for our monthly e-mail newsletter for the latest information on scientific research on aging and health.
Ways to Give
There are many ways you can help accelerate the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health: